Testing of reference samples showed that the batches covered by the decision do not meet specifications for atomoxetine content, and batch 1311190 also fails the mass uniformity parameter. Potential effects: reduced treatment efficacy, variable dosing, possible therapy complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Konaten capsules from the listed batches. Check the batch number on the pack; return any affected packs to the pharmacy and consult your doctor or pharmacist about continuing or adjusting t...
The distribution of the listed batches of Konaten was suspended nationwide and the decision was given immediate enforceability; the manufacturer halted production of atomoxetine-containing products un...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related